Scientist (Immunology), Vienna

The role

This scientist will design and execute immune organoid experiments using primary human cells and stem cell-derived models. The role involves building and validating immune organoid models and advancing disease modelling on the platform.

What you will do

• Design, execute and interpret immune organoid experiments in tissue culture
• Establish, optimize and troubleshoot assays for immune activation, cell phenotyping and functional response
• Connect bench observations to drug development decisions
• Set project direction and decide on experimental priorities
• Run multiple projects concurrently and manage timelines
• Work with computational and automation teams
• Write and implement SOPs
• Produce clear experimental documentation and contribute to reports and presentations
• Share knowledge with peers and mentor junior scientists

Required qualifications

• PhD in immunology, cell biology or a closely related life sciences discipline
• 5+ years of experience in biotech, pharma or a research environment with exposure to translational or drug development contexts
• Broad immunological expertise across innate and adaptive immunity
• Strong practical command of immune cell characterisation
• Experience with secondary lymphoid organ biology
• Strong background in primary cell and tissue culture, including 3D or organoid culture
• Familiarity with immunological characterisation methods including flow cytometry panel design and analysis, multiplex immunoassays and imaging-based readouts
• Comfort with quantitative analysis, including scripting in Python, R or equivalent, data visualisation and working directly with complex datasets
• Track record of driving a project independently
• Ability to troubleshoot complex experimental systems
• Excellent collaborator with a history of working across disciplines and across sites

Nice to have

• Experience with iPSC culture or differentiation
• Experience developing disease-relevant immune models, whether autoimmune, inflammatory or immuno-oncology

Benefits

• Flexible work arrangements may be possible

About the company

Parallel Bio is building a human-first drug discovery platform powered by organoids and AI. The company has raised ~$30M from investors including AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator.